Cargando…
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
BACKGROUND: Approximately 3.5 million Americans are infected with the hepatitis C virus (HCV). Although many patients with HCV are asymptomatic, HCV is the leading cause of infection-related death in the U.S. With advances in curative medication therapy for HCV, many of these deaths are preventable....
Autores principales: | Zullig, Leah L., Bhatia, Haresh L., Gellad, Ziad F., Eatherly, Mark, Henderson, Rochelle, Bosworth, Hayden B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657375/ https://www.ncbi.nlm.nih.gov/pubmed/31345218 http://dx.doi.org/10.1186/s12913-019-4349-x |
Ejemplares similares
-
Selecting, adapting, and sustaining programs in health care systems
por: Zullig, Leah L, et al.
Publicado: (2015) -
The new landscape of medication adherence improvement: where population health science meets precision medicine
por: Zullig, Leah L, et al.
Publicado: (2018) -
A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States
por: Zullig, Leah L, et al.
Publicado: (2016) -
Comparing direct acting antivirals for hepatitis C using observational data – Why and how?
por: Young, Jim, et al.
Publicado: (2020) -
Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)